TY - JOUR
T1 - Progressive disruption of the plasma membrane during renal proximal tubule cellular injury
AU - Chen, Jing
AU - Liu, Xiuli
AU - Mandel, Lazaro J.
AU - Schnellmann, Rick G.
N1 - Funding Information:
This work was supported by a postdoctoral grant to J.C., a Am. Heart Assoc. predoctoral fellowship to X.L., and a grant from the National Institutes of Environmental Health Sciences (ES-09129) to R.G.S. Portions of this work were presented at the American Society of Nephrology meeting on November 2–5, 1997 (J. Am. Soc. Nephrol. 8, 584A–585A, 1997).
PY - 2001/2/15
Y1 - 2001/2/15
N2 - The goal of this study was to examine the progression of plasma membrane disruption during cell injury using rabbit renal proximal tubules (RPT). The results demonstrated that the plasma membrane became permeable to larger and larger molecules as anoxia proceeded. At least three distinctive phases of membrane disruption were differentiated during anoxia. In phases 1, 2, and 3, plasma membranes became permeable to propidium iodide (PI, molecular weight = 668), 3 kDa dextrans, and 70 kDa dextrans or lactate dehydrogenase (LDH, molecular weight = 140 kDa), respectively. Phase 1 was reversible by reoxygenation but not prevented by the glycine. Phase 2 was inhibited by glycine. Phase 3 was inhibited by several membrane-permeable homobifunctional crosslinkers, dimethyl-pimelimidate (DMP), ethylene-glycolbis(succinimidylsuccinate), and dithiobis(succinimidylpropionate), but not by the membrane-impermeable crosslinker dithiobis(sulfosuccinimidylpropionate). In addition, DMP decreased RPT LDH release produced by mitochondrial inhibition (antimycin A), an oxidant (t-butylhydroperoxide) and a nephrotoxicant that is metabolized to an electrophile (tetrafluoroethyl-L-cysteine). These results identify (1) different phases of plasma membrane damage with increasing permeability during cell injury, (2) the reversibility of phase 1, (3) the relative site of action of the cytoprotectant glycine (prevents phase 2), and (4) the protective effects of chemical crosslinkers in RPT cell death produced by different toxicants.
AB - The goal of this study was to examine the progression of plasma membrane disruption during cell injury using rabbit renal proximal tubules (RPT). The results demonstrated that the plasma membrane became permeable to larger and larger molecules as anoxia proceeded. At least three distinctive phases of membrane disruption were differentiated during anoxia. In phases 1, 2, and 3, plasma membranes became permeable to propidium iodide (PI, molecular weight = 668), 3 kDa dextrans, and 70 kDa dextrans or lactate dehydrogenase (LDH, molecular weight = 140 kDa), respectively. Phase 1 was reversible by reoxygenation but not prevented by the glycine. Phase 2 was inhibited by glycine. Phase 3 was inhibited by several membrane-permeable homobifunctional crosslinkers, dimethyl-pimelimidate (DMP), ethylene-glycolbis(succinimidylsuccinate), and dithiobis(succinimidylpropionate), but not by the membrane-impermeable crosslinker dithiobis(sulfosuccinimidylpropionate). In addition, DMP decreased RPT LDH release produced by mitochondrial inhibition (antimycin A), an oxidant (t-butylhydroperoxide) and a nephrotoxicant that is metabolized to an electrophile (tetrafluoroethyl-L-cysteine). These results identify (1) different phases of plasma membrane damage with increasing permeability during cell injury, (2) the reversibility of phase 1, (3) the relative site of action of the cytoprotectant glycine (prevents phase 2), and (4) the protective effects of chemical crosslinkers in RPT cell death produced by different toxicants.
KW - Cell injury and death
KW - Crosslinker
KW - Glycine
KW - Lactate dehydrogenase
KW - Mitochondria
KW - Nephrotoxicant
KW - Oxidant
KW - Plasma membrane disruption
KW - Plasma membrane permeability
KW - Propidium iodide
UR - http://www.scopus.com/inward/record.url?scp=0035865314&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035865314&partnerID=8YFLogxK
U2 - 10.1006/taap.2000.9105
DO - 10.1006/taap.2000.9105
M3 - Article
C2 - 11181106
AN - SCOPUS:0035865314
SN - 0041-008X
VL - 171
SP - 1
EP - 11
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 1
ER -